About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Study for PRO of CML in Real Word | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT05092048

A Study for PRO of CML in Real Word

Successful outcomes in CML require both prolonged adherence to oral TKI therapy by patients and careful monitoring of treatment responses by their physicians. Patient Reported Outcomes(PRO) assessment...

Lead sponsor: xuna•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

na xu, doctor

CONTACT

02062787883 292347668@qq.com

Sponsors

Lead Sponsor

xuna

1. Above 18 years of age. 2. Patient with confirmed diagnosis of Philadelphia chromosome positive and/or BCR-ABL positive chronic myeloid leukemia (CML). 3. Written informed consent. 4. Patients enrolled in investigational drug-trials or other type of clinical trials are also eligible.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Related studies

RECRUITINGPhase 1

Phase I Trial of Vididencel in CML-CP Patients With MRD Under TKI Treatment

NCT07651878 · CML (Chronic Myelogenous Leukemia)

RECRUITINGPhase 2

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

NCT06859424 · AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), and more

Vascular Dysfunction and Antiangiogenic Therapy

NCT02161978 · Solid Tumor, Tumor Angiogenesis, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 25, 2021Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment10,000

Start dateSep 2021

Last updatedOct 25, 2021

Condition

CML (Chronic Myelogenous Leukemia)

Locations shown

Department of Hematology, Nanfang Hospital, Southern Medical University,

Guanzhou

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 25, 2021Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions